Cholecystitis and Gallbladder Rupture

Cholecystitis is defined as inflammation of the gallbladder wall, which may be acute or chronic, and can be classified as calculous (associated with choleliths) or acalculous. Gallbladder rupture is a severe complication of cholecystitis, trauma, or neoplasia, leading to bile peritonitis, a life-threatening condition characterized by the presence of bile in the peritoneal cavity. The gallbladder is a pear-shaped reservoir located in the right cranial abdomen, partially embedded in the visceral surface of the liver, with a capacity of approximately 1-2 mL/kg in dogs and cats. It functions to concentrate and store bile produced by hepatocytes. The cystic duct connects the gallbladder to the common bile duct, which drains into the duodenum at the major duodenal papilla. Bile is composed of bile acids, bilirubin, cholesterol, phospholipids, and electrolytes, and is essential for fat digestion and absorption. Cholecystitis can lead to mural necrosis, ulceration, and subsequent rupture, resulting in chemical and septic peritonitis. Surgical management is often required, including cholecystectomy, cholecystotomy, or biliary diversion, depending on the underlying cause and extent of disease.

The etiology of cholecystitis and gallbladder rupture is multifactorial. Primary causes include: 1) Biliary calculi (choleliths) causing obstruction and inflammation; 2) Infectious agents, such as Escherichia coli, Enterococcus spp., Clostridium spp., and Salmonella spp., which can ascend from the duodenum or spread hematogenously; 3) Trauma, including blunt abdominal trauma (e.g., vehicular accidents) or penetrating wounds, leading to direct rupture; 4) Neoplasia, such as gallbladder adenocarcinoma, leiomyosarcoma, or neuroendocrine tumors, which can cause mural weakening and rupture; 5) Ischemia due to thrombosis, torsion, or vasculitis; 6) Parasitic infections (e.g., Echinococcus, Fasciola) in endemic areas; 7) Iatrogenic causes, such as surgical trauma during liver biopsy or abdominal surgery; 8) Congenital anomalies, including biliary cysts or ectopic bile ducts. In cats, cholangitis-cholangiohepatitis syndrome is a common inflammatory condition that can predispose to cholecystitis. Gallbladder mucocele, a condition characterized by excessive accumulation of mucus and cellular debris within the gallbladder, is a significant risk factor for rupture, particularly in dogs, and is associated with endocrinopathies such as hyperadrenocorticism and hypothyroidism. The exact pathogenesis of mucocele formation is unclear but may involve altered bile composition, decreased gallbladder motility, and increased mucus secretion.

Cholecystitis and gallbladder rupture are relatively uncommon in small animal practice. Dogs are more frequently affected than cats. In dogs, gallbladder mucocele is the most common cause of extrahepatic biliary obstruction and gallbladder rupture, with a higher incidence in breeds such as Shetland Sheepdogs, Cocker Spaniels, Miniature Schnauzers, and Pomeranians. Middle-aged to older dogs (median age 9-10 years) are typically affected, with no strong sex predilection, although some studies suggest a slight female predominance. Cats are more commonly diagnosed with cholangitis-cholangiohepatitis syndrome, which can progress to cholecystitis and rupture, but the overall incidence is lower. Gallbladder rupture secondary to trauma is more common in young, outdoor animals. There is no significant breed predisposition for traumatic rupture. The prevalence of cholelithiasis in dogs is estimated at 1-2%, and in cats at 0.5-1%, but only a minority of these cases develop cholecystitis or rupture. The mortality rate for bile peritonitis is high, ranging from 20-50%, even with aggressive surgical and medical management.

The pathophysiology of cholecystitis and gallbladder rupture involves a cascade of events leading to inflammation, necrosis, and eventual bile leakage. In calculous cholecystitis, choleliths cause mechanical irritation and obstruction of the cystic duct, leading to bile stasis, increased intraluminal pressure, and impaired blood flow to the gallbladder wall. This ischemia promotes mucosal damage, inflammation, and bacterial translocation. In acalculous cholecystitis, factors such as sepsis, hypovolemia, or parenteral nutrition can lead to biliary stasis and ischemia. The inflammatory response involves infiltration of neutrophils, macrophages, and lymphocytes, release of pro-inflammatory cytokines (TNF-α, IL-1, IL-6), and activation of the complement cascade. Prolonged inflammation results in mural edema, hemorrhage, and necrosis, weakening the gallbladder wall. Rupture occurs when the wall integrity is compromised, allowing bile to spill into the peritoneal cavity. Bile peritonitis is a chemical peritonitis initially, due to the cytotoxic effects of bile acids and bilirubin on peritoneal mesothelial cells, causing vasodilation, increased capillary permeability, and fluid exudation. Secondary bacterial infection, often from enteric organisms, leads to septic peritonitis, exacerbating the systemic inflammatory response syndrome (SIRS) and potentially progressing to multiple organ dysfunction syndrome (MODS). The presence of bile in the peritoneal cavity also impairs host defense mechanisms, such as opsonization and phagocytosis, increasing the risk of abscess formation and adhesion development.

Predisposing factors for cholecystitis and gallbladder rupture include: 1) Breed predisposition: Shetland Sheepdogs, Cocker Spaniels, Miniature Schnauzers, and Pomeranians are at higher risk for gallbladder mucocele. 2) Age: Middle-aged to older animals are more commonly affected. 3) Endocrinopathies: Hyperadrenocorticism, hypothyroidism, and diabetes mellitus are associated with gallbladder mucocele formation. 4) Hyperlipidemia: Elevated serum cholesterol and triglycerides may contribute to bile lithogenicity. 5) Obesity: Increases the risk of cholelithiasis and gallbladder disease. 6) Biliary stasis: Conditions such as fasting, parenteral nutrition, or decreased gallbladder motility (e.g., due to vagal dysfunction) predispose to sludge and stone formation. 7) Inflammatory bowel disease: May lead to ascending bacterial infection. 8) Trauma: Blunt or penetrating abdominal trauma can directly rupture the gallbladder. 9) Prior abdominal surgery: Adhesions or iatrogenic injury may compromise gallbladder integrity. 10) Immunosuppression: Increases susceptibility to infectious cholecystitis. 11) Parasitic infections: In endemic areas, liver flukes can cause biliary inflammation and obstruction.

Clinical signs of cholecystitis and gallbladder rupture are variable and may be acute or chronic. Common signs include: 1) Lethargy and depression; 2) Anorexia or decreased appetite; 3) Vomiting, which may be bilious; 4) Abdominal pain, often localized to the right cranial quadrant; 5) Fever or hypothermia, depending on the severity of inflammation and sepsis; 6) Jaundice (icterus) due to extrahepatic biliary obstruction or hepatic dysfunction; 7) Pale mucous membranes and prolonged capillary refill time in cases of septic shock; 8) Tachycardia and tachypnea; 9) Dehydration; 10) In cases of rupture, signs of peritonitis, including abdominal distension, fluid wave, and severe pain. Physical examination may reveal a painful, tense abdomen, and in some cases, a palpable mass in the right cranial abdomen. In chronic cases, weight loss and intermittent vomiting may be observed. In cats, clinical signs may be more subtle, with lethargy and anorexia being the most prominent. It is important to note that some animals with gallbladder rupture may not exhibit overt signs of peritonitis initially, especially if the bile leak is slow and walled off by omentum.

Differential diagnoses for cholecystitis and gallbladder rupture include: 1) Acute pancreatitis: Presents with vomiting, abdominal pain, and elevated pancreatic enzymes (lipase, amylase, PLI). Imaging may show pancreatic enlargement and peripancreatic fat stranding, but gallbladder changes are not primary. 2) Hepatic abscess: Focal liver mass with fever and abdominal pain; ultrasound-guided aspiration may be needed to differentiate. 3) Biliary obstruction due to neoplasia (e.g., pancreatic adenocarcinoma, bile duct carcinoma): May present with jaundice and weight loss; imaging may show a mass and dilated bile ducts. 4) Cholangiohepatitis (especially in cats): Inflammatory liver disease with similar clinical signs; liver biopsy is diagnostic. 5) Gallbladder mucocele without rupture: May be asymptomatic or cause chronic vomiting; ultrasound shows a characteristic stellate or kiwi-like pattern. 6) Peritonitis from other causes (e.g., gastrointestinal perforation, septic peritonitis): Abdominocentesis and imaging can help differentiate. 7) Hepatitis (acute or chronic): May cause jaundice and elevated liver enzymes; liver biopsy is needed. 8) Duodenal ulceration or perforation: Can cause peritonitis and bile peritonitis if the ulcer is near the biliary tree. 9) Cholelithiasis without cholecystitis: May be incidental; ultrasound shows stones but no wall thickening or rupture. 10) Trauma to other abdominal organs (e.g., liver laceration, splenic rupture): May cause hemoperitoneum and abdominal pain; imaging and abdominocentesis are helpful.

The diagnostic algorithm for suspected cholecystitis and gallbladder rupture begins with a thorough history and physical examination. If clinical signs suggest hepatobiliary disease, the following steps are recommended: 1) Complete blood count (CBC), serum biochemistry profile, and urinalysis to assess for leukocytosis, elevated liver enzymes (ALP, ALT, GGT, bilirubin), and electrolyte imbalances. 2) Abdominal radiographs: May reveal loss of abdominal detail due to peritonitis, or radiopaque choleliths (though only 10-20% are radiopaque). 3) Abdominal ultrasound: This is the imaging modality of choice. It can assess gallbladder wall thickness (>2 mm is abnormal), presence of choleliths, sludge, mucocele, pericholecystic fluid, and free abdominal fluid. Ultrasound-guided abdominocentesis or fine-needle aspiration of the gallbladder may be performed, but caution is advised due to risk of bile leakage. 4) If bile peritonitis is suspected, abdominocentesis or diagnostic peritoneal lavage should be performed. Bile fluid has a characteristic dark green-brown color, and cytology may show degenerate neutrophils and intracellular bacteria. Fluid analysis should include bilirubin concentration; if the fluid bilirubin is greater than serum bilirubin, bile peritonitis is confirmed. 5) Advanced imaging: CT or MRI may be used for further characterization, especially if neoplasia is suspected. 6) Exploratory laparotomy is often necessary for definitive diagnosis and treatment, especially if rupture is suspected. Intraoperative findings include bile-stained peritoneal fluid, gallbladder wall necrosis or perforation, and possibly choleliths. 7) Culture and sensitivity of bile and peritoneal fluid should be obtained to guide antimicrobial therapy.

Laboratory findings in cholecystitis and gallbladder rupture are variable but often include: 1) Hematology: Leukocytosis with a left shift, or leukopenia in severe sepsis; thrombocytopenia may occur due to consumptive coagulopathy. 2) Serum biochemistry: Elevated liver enzymes, particularly alkaline phosphatase (ALP) and gamma-glutamyltransferase (GGT), due to cholestasis. Alanine aminotransferase (ALT) may be elevated if there is concurrent hepatocellular damage. Hyperbilirubinemia (total and direct) is common. Other findings may include hypercholesterolemia, hypertriglyceridemia, and elevated bile acids. 3) Coagulation panel: Prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT) may be seen due to vitamin K malabsorption or hepatic dysfunction. 4) Blood gas analysis: May reveal metabolic acidosis due to sepsis or peritonitis. 5) Inflammatory biomarkers: C-reactive protein (CRP) and serum amyloid A (SAA) are often elevated. 6) Peritoneal fluid analysis: If bile peritonitis is present, the fluid will have a bilirubin concentration greater than that of serum, and cytology will show degenerate neutrophils, macrophages, and possibly intracellular bacteria. The fluid may appear dark green or brown. 7) Bile culture: Aerobic and anaerobic culture of bile or peritoneal fluid is essential for guiding antimicrobial therapy. 8) Urinalysis: May show bilirubinuria, which can precede hyperbilirubinemia.

Imaging plays a crucial role in the diagnosis of cholecystitis and gallbladder rupture. 1) Abdominal radiography: May show a loss of serosal detail in the cranial abdomen due to peritonitis, or a soft tissue mass effect in the gallbladder region. Choleliths are radiopaque in only 10-20% of cases. Radiographs are not sensitive for detecting gallbladder rupture. 2) Abdominal ultrasonography: This is the most valuable imaging modality. Findings include: - Gallbladder wall thickening (>2 mm in dogs, >1 mm in cats) with a hypoechoic or hyperechoic appearance. - Gallbladder distension or a change in shape. - Presence of choleliths (hyperechoic foci with acoustic shadowing) or sludge (echogenic material without shadowing). - Gallbladder mucocele: Characteristic stellate or kiwi-like pattern due to inspissated bile. - Pericholecystic fluid or hyperechoic fat surrounding the gallbladder, indicating inflammation. - Free peritoneal fluid, which may be anechoic or have echogenic debris. - In cases of rupture, a defect in the gallbladder wall may be visible, but this is not always apparent. 3) Computed tomography (CT): CT may provide better characterization of the biliary tree and surrounding structures, especially if neoplasia is suspected. It can also detect small amounts of free fluid and peritonitis. 4) Magnetic resonance imaging (MRI): MRI with magnetic resonance cholangiopancreatography (MRCP) can provide detailed images of the biliary tree, but is rarely necessary in veterinary medicine. 5) Hepatobiliary scintigraphy: This nuclear medicine technique can assess bile flow and gallbladder function, but is not widely available. 6) Intraoperative cholangiography: May be performed during surgery to assess the patency of the common bile duct.

Cytology and histopathology are important for confirming the diagnosis and identifying the underlying cause. 1) Fine-needle aspiration of the gallbladder: This is controversial due to the risk of bile leakage, but may be performed under ultrasound guidance. Cytology may show inflammatory cells (neutrophils, macrophages) and bacteria. 2) Peritoneal fluid cytology: In bile peritonitis, the fluid is characterized by a mixed inflammatory population with degenerate neutrophils, macrophages, and extracellular bile pigment. Intracellular bacteria may be seen if septic. 3) Histopathology of the gallbladder: After cholecystectomy, the gallbladder should be submitted for histopathology. Findings may include: - Acute cholecystitis: Neutrophilic infiltration, edema, hemorrhage, and mucosal necrosis. - Chronic cholecystitis: Lymphocytic-plasmacytic infiltration, fibrosis, and mucosal hyperplasia. - Gallbladder mucocele: Accumulation of mucus and cellular debris, with variable inflammation. - Neoplasia: Adenocarcinoma, leiomyosarcoma, etc., with evidence of invasion. 4) Liver biopsy: Concurrent liver disease is common, and a liver biopsy should be obtained during surgery to assess for cholangiohepatitis, hepatic lipidosis, or other pathology. 5) Special stains: Gram stain for bacteria, and possibly immunohistochemistry for specific tumor markers.

Treatment of cholecystitis and gallbladder rupture is primarily surgical, with medical management as an adjunct. 1) Preoperative stabilization: Patients with septic peritonitis or biliary obstruction require aggressive fluid therapy with isotonic crystalloids (e.g., Lactated Ringer's solution at 10-20 mL/kg bolus, then 5-10 mL/kg/hr) and colloids (e.g., hetastarch at 10-20 mL/kg) if hypoproteinemia is present. Broad-spectrum antimicrobials should be initiated immediately, such as ampicillin (22 mg/kg IV q8h) combined with enrofloxacin (10 mg/kg IV q24h) or a third-generation cephalosporin (e.g., cefovecin 8 mg/kg SC q14d). Analgesia with opioids (e.g., hydromorphone 0.05-0.1 mg/kg IV q4-6h) is essential. 2) Surgical techniques: - Cholecystectomy: This is the treatment of choice for cholecystitis, gallbladder rupture, and mucocele. The gallbladder is dissected from the liver bed, and the cystic duct and artery are ligated with 3-0 or 4-0 monofilament absorbable suture (e.g., polydioxanone) or surgical clips. The cystic duct stump should be closed with a ligature or hemoclip. - Cholecystotomy: This may be performed for cholelithiasis without rupture, but is associated with a higher risk of recurrence and bile leakage. The gallbladder is incised, stones are removed, and the incision is closed with a simple continuous pattern using 4-0 monofilament absorbable suture. - Biliary diversion: If the common bile duct is obstructed or ruptured, a choledochotomy with stent placement or a choledochoenterostomy (e.g., choledochoduodenostomy) may be necessary. This is a complex procedure and should be performed by an experienced surgeon. - Omentalization: In cases of localized bile peritonitis, the omentum can be used to fill the gallbladder fossa and promote drainage. 3) Intraoperative management: Thorough abdominal lavage with warm sterile saline (200-300 mL/kg) is essential to remove bile and debris. Multiple samples for culture and sensitivity should be obtained. 4) Postoperative care: Patients require intensive monitoring, including vital signs, urine output, and blood glucose. Analgesia should be continued with opioids and possibly a constant rate infusion (CRI) of lidocaine (25-50 mcg/kg/min) or ketamine (0.1-0.5 mg/kg/hr). Nutritional support may be needed, such as a feeding tube (esophagostomy or gastrostomy) if anorexia persists. 5) Medical management: Antimicrobials should be continued for 2-4 weeks based on culture results. Hepatoprotectants such as S-adenosylmethionine (SAMe) (20 mg/kg PO q24h) and ursodeoxycholic acid (10-15 mg/kg PO q24h) may be beneficial. Vitamin K1 (0.5-1.5 mg/kg SC q12h) should be administered if coagulopathy is present.

The prognosis for cholecystitis without rupture is generally good with appropriate medical and surgical management. However, the prognosis for gallbladder rupture and bile peritonitis is guarded to poor, with reported mortality rates of 20-50%. Factors associated with a worse prognosis include: 1) Septic peritonitis with positive bacterial culture; 2) Hypotension and shock at presentation; 3) Concurrent pancreatitis or hepatic disease; 4) Delayed surgical intervention; 5) Postoperative complications such as bile peritonitis, pancreatitis, or sepsis. In cases of gallbladder mucocele, the prognosis is good if surgery is performed before rupture, with a reported survival rate of 80-90%. However, if rupture has occurred, the survival rate drops to 50-60%. Long-term prognosis is also influenced by the underlying cause; for example, if neoplasia is present, the prognosis is poor. With aggressive treatment and intensive care, many animals can recover, but they may require long-term management of underlying conditions such as hyperadrenocorticism or hyperlipidemia.

Postoperative follow-up is crucial for monitoring recovery and detecting complications. 1) Immediate postoperative period: Patients should be hospitalized for at least 24-72 hours, with monitoring of vital signs, pain scores, and urine output. Blood work (CBC, biochemistry, electrolytes) should be repeated daily or as needed. 2) Suture removal: Skin sutures or staples are typically removed 10-14 days after surgery. 3) Activity restriction: Strict rest for 2 weeks, then gradual return to normal activity over 4-6 weeks. 4) Serial imaging: Abdominal ultrasound may be repeated at 2-4 weeks postoperatively to assess for bile peritonitis, abscess formation, or biliary obstruction. 5) Laboratory monitoring: Liver enzymes and bilirubin should be rechecked at 2 weeks, 4 weeks, and then every 3-6 months, depending on the underlying disease. 6) Antimicrobial therapy: If a bacterial infection was confirmed, antibiotics should be continued for 2-4 weeks, and a repeat culture may be indicated if signs of infection persist. 7) Nutritional support: If a feeding tube was placed, it should be maintained until the animal is eating adequately, usually 1-2 weeks. 8) Long-term management: Underlying conditions such as hyperadrenocorticism or hypothyroidism should be managed appropriately. Regular veterinary check-ups are recommended every 3-6 months.

Clinical Pearls: 1) Always consider gallbladder rupture in any dog with acute abdomen and jaundice, especially if there is a history of gallbladder mucocele. 2) Ultrasound is the most sensitive imaging modality for detecting gallbladder wall thickening and pericholecystic fluid. 3) If bile peritonitis is suspected, perform abdominocentesis and measure fluid bilirubin; a fluid-to-serum bilirubin ratio >1 is diagnostic. 4) In cases of gallbladder mucocele, early surgical intervention is recommended to prevent rupture, even if the patient is asymptomatic. 5) During cholecystectomy, carefully identify the cystic duct and artery to avoid injury to the common bile duct. 6) Always obtain a liver biopsy during surgery to assess for concurrent hepatobiliary disease. 7) Use a closed-suction drain (e.g., Jackson-Pratt) in cases of severe peritonitis to allow postoperative drainage. 8) Administer vitamin K1 preoperatively if coagulopathy is present. Pitfalls: 1) Delaying surgery in cases of suspected rupture can be fatal; do not wait for culture results. 2) Avoid excessive manipulation of the gallbladder during surgery, as this can cause rupture and spillage of bile. 3) Do not ligate the common bile duct inadvertently; always trace the cystic duct to its junction with the common bile duct. 4) Inadequate lavage of the peritoneal cavity can lead to ongoing peritonitis and abscess formation. 5) Failure to provide adequate postoperative analgesia can lead to complications such as pancreatitis. 6) Discontinuing antibiotics too early can lead to recurrent infection. 7) Overlooking concurrent diseases such as pancreatitis or inflammatory bowel disease can affect the outcome.

Perioperative drug protocols based on Plumb's Veterinary Drug Handbook: 1) Antimicrobials: - Ampicillin: 22 mg/kg IV q8h, for broad-spectrum coverage including enterococci. - Enrofloxacin: 10 mg/kg IV q24h (diluted and given slowly over 30 min), for gram-negative coverage. - Metronidazole: 10-15 mg/kg IV q12h, for anaerobic coverage. - Alternatively, cefoxitin: 30 mg/kg IV q2h intraoperatively, then q8h postoperatively. - Continue antibiotics for 2-4 weeks based on culture. 2) Analgesics: - Hydromorphone: 0.05-0.1 mg/kg IV q4-6h. - Fentanyl CRI: 2-5 mcg/kg/hr IV. - Lidocaine CRI: 25-50 mcg/kg/min IV (dogs only). - Ketamine CRI: 0.1-0.5 mg/kg/hr IV. - Maropitant: 1 mg/kg IV q24h for antiemetic and visceral pain. 3) Gastroprotectants: - Omeprazole: 1 mg/kg PO q12h. - Sucralfate: 0.5-1 g PO q8h. 4) Hepatoprotectants: - S-adenosylmethionine (SAMe): 20 mg/kg PO q24h. - Ursodeoxycholic acid: 10-15 mg/kg PO q24h. - Vitamin K1: 0.5-1.5 mg/kg SC q12h for 3 doses if coagulopathy. 5) Fluid therapy: - Lactated Ringer's solution or Normosol-R at 5-10 mL/kg/hr, adjusted based on hydration and losses. - Colloids (hetastarch) 10-20 mL/kg/day if hypoalbuminemia. 6) Nutritional support: - If anorexic, consider esophagostomy tube feeding with a balanced diet (e.g., Hill's a/d) at calculated resting energy requirement (RER = 70 x BW^0.75). 7) Antiemetics: - Maropitant: 1 mg/kg IV q24h. - Ondansetron: 0.1-0.2 mg/kg IV q8h. 8) Corticosteroids: Not recommended unless there is evidence of hypoadrenocorticism or severe inflammatory disease, and then only at physiologic doses.

Key literature on cholecystitis and gallbladder rupture includes: 1) Fossum's Small Animal Surgery (5th edition) provides comprehensive coverage of hepatobiliary surgery, including indications, techniques, and outcomes. 2) Tobias & Johnston's Veterinary Surgery: Small Animal (2nd edition) offers detailed chapters on biliary tract surgery, with emphasis on surgical anatomy and complications. 3) A landmark study by Worley et al. (2004) evaluated the outcome of dogs with gallbladder mucocele and found that dogs treated surgically had a significantly better survival rate than those treated medically. 4) A study by Crews et al. (2009) reported that the presence of bile peritonitis was associated with a higher mortality rate in dogs with gallbladder rupture. 5) A retrospective study by Mehler et al. (2004) compared cholecystectomy and cholecystotomy for the treatment of gallbladder mucocele and found that cholecystectomy was associated with a lower recurrence rate. 6) A study by Pike et al. (2004) evaluated the use of omentalization for the treatment of bile peritonitis and found it to be a useful adjunct. 7) Consensus guidelines from the American College of Veterinary Surgeons (ACVS) recommend early surgical intervention for gallbladder mucocele to prevent rupture. 8) A meta-analysis by Tamborini et al. (2016) evaluated the prognostic factors for survival in dogs with gallbladder rupture and identified septic peritonitis and hypotension as negative prognostic indicators. 9) Studies on antimicrobial therapy have shown that a combination of a beta-lactam and a fluoroquinolone is effective for the treatment of biliary infections. 10) Research on hepatoprotectants such as SAMe and ursodeoxycholic acid has shown benefits in reducing liver enzyme elevations and improving bile flow.